Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Zevra Therapeutics, Inc. (NASDAQ: ZVRA)
ZVRA Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
238.60%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
113.60%
ZVRA Stock Analysis
ZVRA
PE Ratio:
5.5
ZVRA
PEG Ratio:
ZVRA
Forward EPS Growth (12 month):
210.10%
ZVRA
PS Ratio:
5.3
ZVRA
PSG Ratio:
0.1
ZVRA
Forward Revenue Growth (12 month):
45.60%
ZVRA Articles
No data was found